Todas las investigaciones
ReclutamientoOBSERVACIONAL

A New Breath for Malignant Hypertension: Implementation of the HAMA Cohort

This study is gathering vital information about a serious form of very high blood pressure known as malignant hypertension. Even though it's a severe condition that can be life-threatening if not treated, we still don't know enough about it today. This project, called the HAMA Cohort, plans to create the first large database of patients with this condition in the UK. By collecting information from many hospitals, researchers want to understand how common it is now, how doctors are currently treating it, and what happens to patients over time. The goal is to update how we define and diagnose malignant hypertension and eventually create better, evidence-based guidelines for treatment. This research is crucial because current knowledge and recommendations haven't changed much in decades, despite the condition affecting younger adults and having serious health consequences.

De un vistazo

Estado
Reclutamiento
Patrocinador
Centre Hospitalier de PAU
Objetivo de inscripción
1,200
Inicio
20 Sep 2019
Estimación de finalización
20 Sep 2034

¿De qué trata este estudio?

This study, called the HAMA Cohort, is looking into a very serious type of high blood pressure known as malignant hypertension. This isn't just slightly high blood pressure; it's when your blood pressure is extremely high (over 180/110) and is causing immediate damage to your body, particularly your eyes. If left untreated, it can be very dangerous.

Even though it's a severe condition, affecting people often between 35 and 55 years old, there hasn't been much research on it in recent times. This means that doctors are often relying on old information and general advice to treat it because there aren't many up-to-date guidelines based on solid scientific evidence. The aim of this study is to change that by gathering a lot of new information.

The researchers want to create the first big database of patients with malignant hypertension across many hospitals. By doing this, they hope to understand how common the condition is today, how it's being managed, and what happens to patients over several years. This new information will help them update the definition and diagnosis of malignant hypertension, understand its effects on different parts of the body, and ultimately develop much better, evidence-based recommendations for treatment to improve patient care.

Puntos clave

  • This study focuses on malignant hypertension, a very severe form of high blood pressure.
  • It aims to update our understanding and improve treatment recommendations.
  • Participation involves sharing existing medical information; no new treatments are given.
  • The study collects data over a 5-year period for each patient.
  • Your contribution helps future patients with this condition.

¿Quién puede ser elegible?

To be part of this study, you would need to have malignant hypertension. This usually means your blood pressure is very high (over 180/110 for the top number and over 110 for the bottom number) and doctors can see specific issues, such as severe changes in the back of your eyes (retinopathy) linked to high blood pressure. Alternatively, you might be eligible if you have very high blood pressure (over 180/110) along with acute damage to three different organs in your body caused by this high blood pressure.

You cannot join the study if you are under 18 years old. Also, if you are unable to freely agree to take part, or if you decide you don't wish to participate, you won't be included. Patients who are currently on dialysis treatment for kidney failure also cannot take part in this study.

¿Podría este estudio ser adecuado para ti?

Responde estas preguntas rápidas para ver si puedes ser elegible. Esto es solo una guía: el equipo de investigación toma la decisión final.

  1. Is your blood pressure very high (over 180/110)?
  2. Have doctors diagnosed you with severe eye problems (retinopathy) because of your high blood pressure?
  3. Or, do you have very high blood pressure causing acute damage to three different organs in your body?
  4. ¿Tienes 18 años o más?
  5. Are you not currently receiving dialysis treatment for kidney failure?
Responde cada pregunta para ver tu resultado.

¿En qué consiste la participación?

This study is a 'registry,' which means it primarily involves collecting health information over time rather than giving new treatments. If you choose to take part, researchers will collect anonymous information from your medical records related to your malignant hypertension. This would include details about your diagnosis, how your condition is being managed, and how it progresses over the next five years. You won't be asked to take any new or different medications specifically for this study, nor will you have extra clinic visits beyond your usual medical care. The study aims to follow how your condition develops under your standard medical treatment, without changing anything about your care. The total duration of data collection for each patient is expected to be five years.

Riesgos y beneficios potenciales

There are no direct medical benefits like new treatments from taking part, as this is an observational study collecting information. However, by contributing your data, you will be helping doctors better understand malignant hypertension, leading to improved diagnosis and care for future patients. There are no notable risks involved, as you will not undergo any new procedures or take different medicines specifically for the study. Your medical care will remain exactly as it would be normally. Your information will be kept confidential, and you are free to withdraw from the study at any time without affecting your medical treatment.

Locations (37)

  • CH d'Annecy
    Código postal verificado
    Annecy, France· Reclutamiento
  • CH de la côte Basque
    Código postal verificado
    Bayonne, France· Reclutamiento
  • Avicenne APHP
    Código postal verificado
    Bobigny, France· Reclutamiento
  • CHU - Hôpital St André
    Código postal verificado
    Burdeos, Francia· Reclutamiento
  • CH de Chalon sur Saone
    Código postal verificado
    Chalon-sur-Saône, France· Reclutamiento
  • CH Métropole
    Código postal verificado
    Chambéry, France· Reclutamiento
  • CHU de Clermont FERRAND
    Código postal verificado
    Clermont-Ferrand, France· Reclutamiento
  • Hôpital Henri Mondor
    Código postal verificado
    Créteil, France· Reclutamiento
  • CH de Dinard
    Código postal verificado
    Dinard, France· Reclutamiento
  • CHU Michallon
    Código postal verificado
    Grenoble, Francia· Reclutamiento
  • hôpital de Haguenau
    Código postal verificado
    Haguenau, France· Reclutamiento
  • Pôle Santé Sud
    Código postal verificado
    Le Mans, France· Reclutamiento

Preguntas comunes

What is malignant hypertension?

It's a very severe form of high blood pressure where your blood pressure is extremely high and is causing damage to your body, especially your eyes or other organs.

Why is this research important?

There hasn't been much new research on malignant hypertension for a long time. This study aims to gather up-to-date information to improve diagnosis and treatment guidelines for patients.

¿Recibiré un nuevo tratamiento en este estudio?

No, this is a registry, meaning it collects information from your existing medical care. You will continue with your standard treatment as prescribed by your doctor.

¿Cuánto tiempo estaré involucrado en el estudio?

The study aims to collect information about your health over a five-year period.

¿Está segura mi información personal?

Yes, your information will be collected anonymously and kept strictly confidential. Your privacy is a priority.

Cómo obtener más información

Siempre hable con su médico de cabecera o especialista antes de decidir participar en un estudio.

¿Interesado en participar?

Registra tu interés

Comparte tus detalles y el equipo de investigación para "A New Breath for Malignant Hypertension: Implementation of t…" se pondrá en contacto contigo si puedes ser elegible. Siempre habla con tu médico antes de aceptar participar.

Discusión

Discusión comunitaria

Impulsado por nuestro foro en community.patient.info. Por favor, sea respetuoso — esto no es un consejo médico.